Comparison

Combretastatin A4 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 5 mg
Quantity options 10 mM/1mL 10 mg 25 mg 5 mg
Item no. HY-N2146-5mg
CASRN 117048-59-6
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin with Kd of 0.4 μM.
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
316.35
Clinical_Information
Phase 2
Manufacturers Research_Area
Cancer
Solubility
DMSO : 100 mg/mL (ultrasonic)
Manufacturers Target
Microtubule/Tubulin
Manufacturers Pathway
Cell Cycle/DNA Damage; Cytoskeleton
Manufacturers Product type
Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close